Top brokers name 3 ASX shares to buy next week

Investor sitting in front of multiple screens watching share prices

Investor sitting in front of multiple screens watching share prices

It has been another busy week for Australia’s top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think these ASX shares are in the buy zone:

Coles Group Ltd (ASX: COL)

According to a note out of Citi, its analysts have retained their buy rating on this supermarket giant’s shares with an improved price target of $19.00. Citi was happy with the company’s performance during the first half. Pleasingly, it believes it has more levers to pull to improve profitability and is forecasting earnings growth comfortably ahead of expectations in FY 2025. The Coles share price ended the week at $17.08.

Pro Medicus Limited (ASX: PME)

A note out of Macquarie reveals that its analysts have retained their outperform rating and $120.00 price target on this health imaging technology company’s shares. Macquarie believes that recent share price weakness has created an opening for investors. Particularly given how its shares are now trading on multiples that are largely in line with five-year averages. The Pro Medicus share price was fetching $103.39 at Friday’s close.

Xero Ltd (ASX: XRO)

Analysts at Goldman Sachs have retained their buy rating on this cloud accounting platform provider’s shares with an increased price target of $152.00. According to the note, Goldman left Xero’s investor day event feeling very bullish on its outlook. It notes that Xero is increasingly positive on its financial outlook and has upgraded its use of the Rule of 40. It has gone from a calling the rule a useful measure to a formal aspiration. The Xero share price ended the week at $134.93.

The post Top brokers name 3 ASX shares to buy next week appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

See The 5 Stocks
*Returns as of 1 February 2024

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Macquarie Group, Pro Medicus, and Xero. The Motley Fool Australia has positions in and has recommended Coles Group, Macquarie Group, and Xero. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/h2PlLVt

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *